Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Massive blow-out craters formed by hydrate-controlled methane expulsion from the Arctic seafloor.

Andreassen K, Hubbard A, Winsborrow M, Patton H, Vadakkepuliyambatta S, Plaza-Faverola A, Gudlaugsson E, Serov P, Deryabin A, Mattingsdal R, Mienert J, Bünz S.

Science. 2017 Jun 2;356(6341):948-953. doi: 10.1126/science.aal4500.

PMID:
28572390
2.

Hepatoid adenocarcinoma of the stomach--proper identification and treatment remain a challenge.

Søreide JA, Greve OJ, Gudlaugsson E, Størset S.

Scand J Gastroenterol. 2016;51(6):646-53. doi: 10.3109/00365521.2015.1124286. Epub 2016 Jan 5. Review.

3.

Low Protein A20 in Minor Salivary Glands is Associated with Lymphoma in Primary Sjögren's Syndrome.

Johnsen SJ, Gudlaugsson E, Skaland I, Janssen EA, Jonsson MV, Helgeland L, Berget E, Jonsson R, Omdal R.

Scand J Immunol. 2016 Mar;83(3):181-7. doi: 10.1111/sji.12405.

4.

Adult pancreatic hemangioma in pregnancy--concerns and considerations of a rare case.

Søreide JA, Greve OJ, Gudlaugsson E.

BMC Surg. 2015 Oct 30;15:119. doi: 10.1186/s12893-015-0106-1.

5.

Epidemiology and classification of gastroenteropancreatic neuroendocrine neoplasms using current coding criteria.

Sandvik OM, Søreide K, Gudlaugsson E, Kvaløy JT, Søreide JA.

Br J Surg. 2016 Feb;103(3):226-32. doi: 10.1002/bjs.10034. Epub 2015 Oct 29.

6.

Surgery for gastrointestinal stromal tumors (GISTs) of the stomach and small bowel: short- and long-term outcomes over three decades.

Sandvik OM, Søreide K, Gudlaugsson E, Søreide JA.

World J Surg. 2015 Feb;39(2):446-52. doi: 10.1007/s00268-014-2824-4.

PMID:
25315092
7.

Prediction of spontaneous regression of cervical intraepithelial neoplasia lesions grades 2 and 3 by proteomic analysis.

Uleberg KE, Ovestad IT, Munk AC, Brede C, van Diermen B, Gudlaugsson E, Janssen EA, Hjelle A, Baak JP.

Int J Proteomics. 2014;2014:129064. doi: 10.1155/2014/129064. Epub 2014 Jun 15.

8.

Prognostic comparison of proliferation markers and World Health Organization 1973/2004 grades in urothelial carcinomas of the urinary bladder.

Mangrud OM, Gudlaugsson E, Skaland I, Tasdemir I, Dalen I, van Diermen B, Baak JP, Janssen EA.

Hum Pathol. 2014 Jul;45(7):1496-503. doi: 10.1016/j.humpath.2014.03.001. Epub 2014 Mar 26.

PMID:
24796506
9.

Prognostic value of gene signatures and proliferation in lymph-node-negative breast cancer.

Jonsdottir K, Assmus J, Slewa A, Gudlaugsson E, Skaland I, Baak JP, Janssen EA.

PLoS One. 2014 Mar 5;9(3):e90642. doi: 10.1371/journal.pone.0090642. eCollection 2014.

10.

Reproducibility and prognostic value of WHO1973 and WHO2004 grading systems in TaT1 urothelial carcinoma of the urinary bladder.

Mangrud OM, Waalen R, Gudlaugsson E, Dalen I, Tasdemir I, Janssen EA, Baak JP.

PLoS One. 2014 Jan 7;9(1):e83192. doi: 10.1371/journal.pone.0083192. eCollection 2014.

11.

Short term results of complete (D3) vs. standard (D2) mesenteric excision in colon cancer shows improved outcome of complete mesenteric excision in patients with TNM stages I-II.

Storli KE, Søndenaa K, Furnes B, Nesvik I, Gudlaugsson E, Bukholm I, Eide GE.

Tech Coloproctol. 2014 Jun;18(6):557-64. doi: 10.1007/s10151-013-1100-1. Epub 2013 Dec 20.

PMID:
24357446
12.

The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer.

Klintman M, Strand C, Ahlin C, Beglerbegovic S, Fjällskog ML, Grabau D, Gudlaugsson E, Janssen EA, Lövgren K, Skaland I, Bendahl PO, Malmström P, Baak JP, Fernö M.

PLoS One. 2013 Dec 4;8(12):e81902. doi: 10.1371/journal.pone.0081902. eCollection 2013.

13.

The total number of lymph nodes in resected colon cancer specimens is affected by several factors but the lymph node ratio is independent of these.

Stanisavljević L, Søndenaa K, Storli KE, Leh S, Nesvik I, Gudlaugsson E, Bukholm I, Eide GE.

APMIS. 2014 Jun;122(6):490-8. doi: 10.1111/apm.12196. Epub 2013 Oct 26.

PMID:
24164093
14.

Can proliferation biomarkers reliably predict recurrence in World Health Organization 2003 defined endometrial stromal sarcoma, low grade?

Feng W, Malpica A, Skaland I, Gudlaugsson E, Robboy SJ, Dalen I, Hua K, Zhou X, Baak JP.

PLoS One. 2013 Oct 11;8(10):e75899. doi: 10.1371/journal.pone.0075899. eCollection 2013.

16.

Prognostic value of the diagnostic criteria distinguishing endometrial stromal sarcoma, low grade from undifferentiated endometrial sarcoma, 2 entities within the invasive endometrial stromal neoplasia family.

Feng W, Malpica A, Robboy SJ, Gudlaugsson E, Hua K, Zhou X, Baak JP.

Int J Gynecol Pathol. 2013 May;32(3):299-306. doi: 10.1097/PGP.0b013e318229adfb.

PMID:
23545579
17.

Diagnostic and prognostic morphometric features in WHO2003 invasive endometrial stromal tumours.

Feng W, Malpica A, Yinhua Y, Janssen E, Gudlaugsson E, Zhou X, Baak JP.

Histopathology. 2013 Apr;62(5):688-94. doi: 10.1111/j.1365-2559.2011.04120.x.

PMID:
23530584
18.

Prognostic indicators in WHO 2003 low-grade endometrial stromal sarcoma.

Feng W, Hua K, Gudlaugsson E, Yu Y, Zhou X, Baak JP.

Histopathology. 2013 Apr;62(5):675-87. doi: 10.1111/j.1365-2559.2011.04115.x. Epub 2013 Feb 21.

PMID:
23425310
19.

Validation of expression patterns for nine miRNAs in 204 lymph-node negative breast cancers.

Jonsdottir K, Janssen SR, Da Rosa FC, Gudlaugsson E, Skaland I, Baak JP, Janssen EA.

PLoS One. 2012;7(11):e48692. doi: 10.1371/journal.pone.0048692. Epub 2012 Nov 7.

20.

Consistent condom use increases spontaneous regression in high-risk non-HPV16 but not in HPV16 CIN2-3 lesions, a prospective population-based cohort study.

Munk AC, Ovestad IT, Gudlaugsson E, Løvslett K, Fiane B, van Diermen-Hidle B, Kruse AJ, Skaland I, Janssen EA, Baak JP.

Infect Agent Cancer. 2012 Nov 5;7(1):30. doi: 10.1186/1750-9378-7-30.

21.

Consistent condom use increases the regression rate of cervical intraepithelial neoplasia 2-3.

Munk AC, Gudlaugsson E, Malpica A, Fiane B, Løvslett KI, Kruse AJ, Øvestad IT, Voorhorst F, Janssen EA, Baak JP.

PLoS One. 2012;7(9):e45114. doi: 10.1371/journal.pone.0045114. Epub 2012 Sep 13.

22.

Interaction of epithelial biomarkers, local immune response and condom use in cervical intraepithelial neoplasia 2-3 regression.

Munk AC, Gudlaugsson E, Ovestad IT, Lovslett K, Fiane B, Hidle Bv, Kruse AJ, Skaland I, Janssen EA, Baak JP.

Gynecol Oncol. 2012 Dec;127(3):489-94. doi: 10.1016/j.ygyno.2012.09.010. Epub 2012 Sep 24.

PMID:
23017821
23.

Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer.

Gudlaugsson E, Skaland I, Janssen EA, Smaaland R, Shao Z, Malpica A, Voorhorst F, Baak JP.

Histopathology. 2012 Dec;61(6):1134-44. doi: 10.1111/j.1365-2559.2012.04329.x. Epub 2012 Sep 11.

PMID:
22963617
24.

Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome.

Søreide K, Sandvik OM, Søreide JA, Gudlaugsson E, Mangseth K, Haugland HK.

Clin Transl Oncol. 2012 Aug;14(8):619-29. doi: 10.1007/s12094-012-0851-x. Epub 2012 Jul 18.

PMID:
22855146
25.

The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer.

Jonsdottir K, Zhang H, Jhagroe D, Skaland I, Slewa A, Björkblom B, Coffey ET, Gudlaugsson E, Smaaland R, Janssen EA, Baak JP.

Breast Cancer Res Treat. 2012 Sep;135(2):381-90. doi: 10.1007/s10549-012-2155-9. Epub 2012 Jul 8.

PMID:
22772381
26.

Improved lymph node harvest from resected colon cancer specimens did not cause upstaging from TNM stage II to III.

Storli K, Søndenaa K, Furnes B, Leh S, Nesvik I, Bru T, Gudlaugsson E, Bukholm I, Norheim-Andersen S, Eide G.

World J Surg. 2011 Dec;35(12):2796-803. doi: 10.1007/s00268-011-1248-7.

PMID:
21879420
27.

Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3.

Ovestad IT, Vennestrøm U, Andersen L, Gudlaugsson E, Munk AC, Malpica A, Feng W, Voorhorst F, Janssen EA, Baak JP.

Gynecol Oncol. 2011 Nov;123(2):278-83. doi: 10.1016/j.ygyno.2011.07.024. Epub 2011 Aug 10.

PMID:
21835440
28.

Discrimination of grade 2 and 3 cervical intraepithelial neoplasia by means of analysis of water soluble proteins recovered from cervical biopsies.

Uleberg KE, Munk AC, Brede C, Gudlaugsson E, van Diermen B, Skaland I, Malpica A, Janssen EA, Hjelle A, Baak JP.

Proteome Sci. 2011 Jun 28;9:36. doi: 10.1186/1477-5956-9-36.

29.

A protein profile study to discriminate CIN lesions from normal cervical epithelium.

Uleberg KE, Munk AC, Skaland I, Furlan C, van Diermen B, Gudlaugsson E, Janssen EA, Malpica A, Feng W, Hjelle A, Baak JP.

Cell Oncol (Dordr). 2011 Oct;34(5):443-50. doi: 10.1007/s13402-011-0047-3. Epub 2011 May 15.

30.

Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma.

Steinbakk A, Malpica A, Slewa A, Skaland I, Gudlaugsson E, Janssen EA, Løvslett K, Fiane B, Kruse AJ, Feng W, Yinhua Y, Baak JP.

Mod Pathol. 2011 Sep;24(9):1262-71. doi: 10.1038/modpathol.2011.75. Epub 2011 May 6.

31.

High frequency microsatellite instability has a prognostic value in endometrial endometrioid adenocarcinoma, but only in FIGO stage 1 cases.

Steinbakk A, Malpica A, Slewa A, Gudlaugsson E, Janssen EA, Arends M, Kruse AJ, Yinhua Y, Feng W, Baak JP.

Cell Oncol (Dordr). 2011 Oct;34(5):457-65. doi: 10.1007/s13402-011-0040-x. Epub 2011 May 6. Erratum in: Cell Oncol (Dordr). 2011 Oct;34(5):509-10.

PMID:
21547578
32.

Epidemiology of gastrointestinal stromal tumours: single-institution experience and clinical presentation over three decades.

Sandvik OM, Søreide K, Kvaløy JT, Gudlaugsson E, Søreide JA.

Cancer Epidemiol. 2011 Dec;35(6):515-20. doi: 10.1016/j.canep.2011.03.002. Epub 2011 Apr 12.

PMID:
21489899
33.

The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2-3.

Ovestad IT, Gudlaugsson E, Skaland I, Malpica A, Munk AC, Janssen EA, Baak JP.

J Clin Pathol. 2011 Apr;64(4):303-7. doi: 10.1136/jcp.2010.083626.

PMID:
21421698
34.

The prognostic value of the orphan nuclear receptor DAX-1 (NROB1) in node-negative breast cancer.

Zhang H, Slewa A, Janssen E, Skaland I, Yu Y, Gudlaugsson E, Feng W, Kjellevold K, Søiland H, Baak JP.

Anticancer Res. 2011 Feb;31(2):443-9.

PMID:
21378322
35.

Molecular biomarkers in endometrial hyperplasias predict cancer progression.

Steinbakk A, Gudlaugsson E, Aasprong OG, Skaland I, Malpica A, Feng W, Janssen EA, Baak JP.

Am J Obstet Gynecol. 2011 Apr;204(4):357.e1-12. doi: 10.1016/j.ajog.2010.12.007. Epub 2011 Feb 16.

PMID:
21324435
36.

D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients.

Gudlaugsson E, Skaland I, Undersrud E, Janssen EA, Søiland H, Baak JP.

Mod Pathol. 2011 Apr;24(4):502-11. doi: 10.1038/modpathol.2010.199. Epub 2011 Feb 11.

37.

In patients younger than age 55 years with lymph node-negative breast cancer, proliferation by mitotic activity index is prognostically superior to adjuvant!

Lende TH, Janssen EA, Gudlaugsson E, Voorhorst F, Smaaland R, van Diest P, Søiland H, Baak JP.

J Clin Oncol. 2011 Mar 1;29(7):852-8. doi: 10.1200/JCO.2009.25.0407. Epub 2010 Dec 28.

PMID:
21189388
38.

High frequency microsatellite instability has a prognostic value in endometrial endometrioid adenocarcinoma, but only in FIGO stage 1 cases.

Steinbakk A, Malpica A, Slewa A, Gudlaugsson E, Janssen EA, Arends M, Kruse AJ, Yinhua Y, Feng W, Baak JP.

Anal Cell Pathol (Amst). 2010;33(5):245-55. doi: 10.3233/ACP-CLO-2010-0550.

39.

Biologic profiling of lymph node negative breast cancers by means of microRNA expression.

Janssen EA, Slewa A, Gudlaugsson E, Jonsdottir K, Skaland I, Søiland H, Baak JP.

Mod Pathol. 2010 Dec;23(12):1567-76. doi: 10.1038/modpathol.2010.177. Epub 2010 Sep 3.

40.

Thrombotic microangiopathy and the antiphospholipid syndrome.

Johnsen SJ, Valborgland T, Gudlaugsson E, Bostad L, Omdal R.

Lupus. 2010 Nov;19(13):1569-72. doi: 10.1177/0961203310375262. Epub 2010 Jul 20.

PMID:
20647251
41.

Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression.

Øvestad IT, Gudlaugsson E, Skaland I, Malpica A, Kruse AJ, Janssen EA, Baak JP.

Mod Pathol. 2010 Sep;23(9):1231-40. doi: 10.1038/modpathol.2010.109. Epub 2010 May 28.

42.

LOH at 1p31 (ARHI) and proliferation in lymph node-negative breast cancer.

Janssen EA, Øvestad IT, Skaland I, Søiland H, Gudlaugsson E, Kjellevold KH, Nysted A, Søreide JA, Baak JP.

Cell Oncol. 2009;31(5):335-43. doi: 10.3233/CLO-2009-0479.

43.

Evaluation of 5 different labeled polymer immunohistochemical detection systems.

Skaland I, Nordhus M, Gudlaugsson E, Klos J, Kjellevold KH, Janssen EA, Baak JP.

Appl Immunohistochem Mol Morphol. 2010 Jan;18(1):90-6. doi: 10.1097/PAI.0b013e3181b0eaad.

PMID:
19661787
44.
45.

Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer.

Gudlaugsson E, Skaland I, Janssen EA, van Diest PJ, Voorhorst FJ, Kjellevold K, zur Hausen A, Baak JP.

Breast Cancer Res Treat. 2010 May;121(1):35-40. doi: 10.1007/s10549-009-0442-x. Epub 2009 Jul 1.

PMID:
19568929
46.

Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.

Søiland H, Skaland I, Varhaug JE, Kørner H, Janssen EA, Gudlaugsson E, Baak JP, Søreide JA.

Acta Oncol. 2009;48(4):514-21. doi: 10.1080/02841860802620613.

PMID:
19107621
47.

The prognostic value of molecular biomarkers in tissue removed by curettage from FIGO stage 1 and 2 endometrioid type endometrial cancer.

Steinbakk A, Skaland I, Gudlaugsson E, Janssen EA, Kjellevold KH, Klos J, Løvslett K, Fiane B, Baak JP.

Am J Obstet Gynecol. 2009 Jan;200(1):78.e1-8. doi: 10.1016/j.ajog.2008.07.020. Epub 2008 Oct 30.

PMID:
18976730
48.

Prognostic relevance of androgen receptor detection in operable breast cancer.

Søiland H, Kørner H, Skaland I, Janssen EA, Gudlaugsson E, Varhaug JE, Baak JP, Søreide JA.

J Surg Oncol. 2008 Dec 1;98(7):551-8. doi: 10.1002/jso.21156.

PMID:
18937259
49.

Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers.

Baak JP, Gudlaugsson E, Skaland I, Guo LH, Klos J, Lende TH, Søiland H, Janssen EA, Zur Hausen A.

Breast Cancer Res Treat. 2009 May;115(2):241-54. doi: 10.1007/s10549-008-0126-y. Epub 2008 Jul 30. Review.

PMID:
18665447
50.

Comparison of apolipoprotein D determination methods in breast cancer.

Søiland H, Skaland I, Janssen EA, Gudlaugsson E, Körner H, Varhaug JE, Søreide JA, Baak JP.

Anticancer Res. 2008 Mar-Apr;28(2B):1151-60.

Supplemental Content

Loading ...
Support Center